Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial.
Thomas MG, Bayliss C, Bond S, Dowling F, Galea J, Jairath V, Lamb C, Probert C, Timperley-Preece E, Watson A, Whitehead L, Williams JG, Parkes M, Kaser A, Raine T. Thomas MG, et al. Among authors: dowling f. BMJ Open. 2019 Feb 15;9(2):e023765. doi: 10.1136/bmjopen-2018-023765. BMJ Open. 2019. PMID: 30772849 Free PMC article.
Predicting outcomes for Crohn's disease using a molecular biomarker: profile trial.
Noor N, Brezina B, Negro JR, Dowling F, Bond S, Whitehead L, Lee J, Lyons P, McKinney E, Smith K, Lee J, Parkes M. Noor N, et al. Among authors: dowling f. Clin Med (Lond). 2022 Jul;22(Suppl 4):22-23. doi: 10.7861/clinmed.22-4-s22. Clin Med (Lond). 2022. PMID: 36220241 Free PMC article. Clinical Trial. No abstract available.
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).
Lennox B, Yeeles K, Jones PB, Zandi M, Joyce E, Yu LM, Tomei G, Pollard R, Vincent SA, Shimazaki M, Cairns I, Dowling F, Kabir T, Barnes TRE, Lingford Hughes A, Hosseini AA, Harrower T, Buckley C, Coles A. Lennox B, et al. Among authors: dowling f. Trials. 2019 Jun 7;20(1):331. doi: 10.1186/s13063-019-3336-1. Trials. 2019. PMID: 31174586 Free PMC article.
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
Sackley CM, Rick C, Au P, Brady MC, Beaton G, Burton C, Caulfield M, Dickson S, Dowling F, Hughes M, Ives N, Jowett S, Masterson-Algar P, Nicoll A, Patel S, Smith CH, Woolley R, Clarke CE; PD COMM Collaborative Group. Sackley CM, et al. Among authors: dowling f. Trials. 2020 May 27;21(1):436. doi: 10.1186/s13063-020-04354-7. Trials. 2020. PMID: 32460885 Free PMC article.
Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer.
Sundar S, Rick C, Dowling F, Au P, Snell K, Rai N, Champaneria R, Stobart H, Neal R, Davenport C, Mallett S, Sutton A, Kehoe S, Timmerman D, Bourne T, Van Calster B, Gentry-Maharaj A, Menon U, Deeks J; ROCkeTS study group. Sundar S, et al. Among authors: dowling f. BMJ Open. 2016 Aug 9;6(8):e010333. doi: 10.1136/bmjopen-2015-010333. BMJ Open. 2016. PMID: 27507231 Free PMC article.
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).
Sackley CM, Smith CH, Rick CE, Brady MC, Ives N, Patel S, Woolley R, Dowling F, Patel R, Roberts H, Jowett S, Wheatley K, Kelly D, Sands G, Clarke CE; PD COMM Pilot Collaborative Group. Sackley CM, et al. Among authors: dowling f. Pilot Feasibility Stud. 2018 Jan 10;4:30. doi: 10.1186/s40814-017-0222-z. eCollection 2018. Pilot Feasibility Stud. 2018. PMID: 29344405 Free PMC article.
Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial.
Sackley CM, Smith CH, Rick C, Brady MC, Ives N, Patel R, Roberts H, Dowling F, Jowett S, Wheatley K, Patel S, Kelly D, Sands G, Clarke C. Sackley CM, et al. Among authors: dowling f. Trials. 2014 Jun 7;15:213. doi: 10.1186/1745-6215-15-213. Trials. 2014. PMID: 24908096 Free PMC article. Clinical Trial.
Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners.
Smith CH, Patel S, Woolley RL, Brady MC, Rick CE, Halfpenny R, Rontiris A, Knox-Smith L, Dowling F, Clarke CE, Au P, Ives N, Wheatley K, Sackley CM. Smith CH, et al. Among authors: dowling f. Clin Linguist Phon. 2019;33(10-11):1063-1070. doi: 10.1080/02699206.2019.1604806. Epub 2019 Apr 29. Clin Linguist Phon. 2019. PMID: 31035809
127 results